Arch Biopartners Inc. (ACHFF)
OTCMKTS · Delayed Price · Currency is USD
0.5900
+0.0100 (1.72%)
Jul 28, 2026, 12:36 PM EST

Arch Biopartners Ratios and Metrics

Millions USD. Fiscal year is Oct - Sep.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
3961845113684
Market Cap Growth
-49.91%-27.29%65.75%-62.68%61.25%34.83%
Enterprise Value
4163885413989
Last Close Price
0.580.921.300.812.181.36

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
PS Ratio
347.92308.4653.5134.58193.3927.41
PB Ratio
-15.09-21.93-26.11-12.45-41.73-27.44
P/OCF Ratio
----389.08-

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
EV/Sales Ratio
-317.7255.9737.12197.5928.88

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Debt / Equity Ratio
-0.75-0.73-0.64-0.91-0.99-1.33
Net Debt / Equity Ratio
-0.63-0.73-0.64-0.76-0.87-1.22
Asset Turnover
0.310.532.012.210.592.28
Quick Ratio
0.110.020.170.190.210.83
Current Ratio
0.110.030.180.200.220.84
Return on Assets (ROA)
-276.77%-136.33%-205.03%-201.92%-37.89%-30.04%
Return on Capital Employed (ROCE)
61.50%29.20%79.50%60.30%46.20%157.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Earnings Yield
-5.06%-1.82%-3.45%-4.85%-0.76%-1.10%
Buyback Yield / Dilution
-4.29%-3.51%-1.46%-0.49%-1.36%-2.34%